GEM-DIMER

Owner

Goods & Services

Pharmaceutical preparations comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions; pharmaceutical agents comprising of monospecific, bispecific, or multi-specific antibody based molecules for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions; monospecific, bispecific, or multi-specific antibody based molecules as a component in pharmaceutical preparations for the treatment of human diseases, namely, autoimmune, inflammatory, oncologic and neoplastic, infectious, cardiovascular, metabolic, endocrine, respiratory, musculoskeletal, neuromuscular, neurologic, mental health, dermatologic, ophthalmologic, hematologic, renal, gastrointestinal and digestive system, urogenital, reproductive, pediatric and developmental, neurodevelopmental, genetic, rare, namely, chronic, progressive, and life-threatening, and orphan diseases and disorders, conditions related to transplantation and tolerance, and immune mediated conditions